Back to news

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Business Wire•18/11/2026•16:05 ET
1

Key Highlights

  • ➤Arcus Biosciences (RCUS) will participate in two investor conferences December 1-2, 2026
  • ➤Management will host an Evercore Healthcare Conference fireside chat December 1
  • ➤Management will host a Citi Global Healthcare Conference fireside chat December 2
  • ➤Casdatifan and quemliclustat have advanced to Phase 3 clinical trials

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and immune diseases, announced that its management team will participate in the following upcoming investor conferences in December:

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in